Aportaciones de un comité multidisciplinar para la prevención de infecciones en pacientes tratados con inmunosupresores selectivos

Mateo, Lourdes; Pedro-Botet, M. Luisa; Guadalupe Esteve, María; Manuel Carrascosa, José.
Med. clín (Ed. impr.) ; 157(10): 489-494, noviembre 2021. tab, mapas
Artículo en Español | IBECS (España) | ID: ibc-215895

Documentos relacionados

  1. In Reply to Best Practice for Induction of Immunosuppression in Patients Treated With Daratumumab Is to Be Determined.
  2. La terapia immunosoppressiva erogata ai pazienti dopo trapianto di cuore o polmone: lo studio Cesit.
  3. Best Practice for Induction of Immunosuppression in Patients Treated With Daratumumab Is to Be Determined.
  4. Vaccines: Considerations for pediatric dermatology patients on immunosuppressive agents.
  5. Effects of systemic targeted immunosuppressive therapy on ocular surface.
  6. A retrospective cohort review of infectious disease findings in patients screened before immunosuppressant therapy.
  7. Aportaciones de un comité multidisciplinar para la prevención de infecciones en pacientes tratados con inmunosupresores selectivos
  8. Impact of the implementation of a pharmacist-driven immunosuppression drug monitoring protocol for hematopoietic stem cell transplant recipients.
  9. Feasibility of discontinuing immunosuppression in children with idiopathic nephrotic syndrome.
  10. Expression of Rejection-Associated Transcripts in Early Protocol Renal Transplant Biopsies Is Associated with Tacrolimus Exposure and Graft Outcome.